Latest Ticlopidine Stories
Heart attack patients taking selective serotonin reuptake inhibitors (SSRIs) in combination with antiplatelet therapy -- acetylsalicylic acid (ASA), clopidogrel or both (dual antiplatelet therapy) -- are at higher risk of bleeding than patients taking ASA alone.
Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate clopidogrel dosing and who had high residual platelet reactivity (platelets resistant to antithrombotic therapy) were at an increased risk of an ischemic event at short- and long-term follow-up of up to 2 years.
SAN DIEGO, May 18 /PRNewswire/ -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a new agreement with Medico's Hirata for distribution of its VerifyNow System in Japan.
According to a new guideline from the American Society for Gastrointestinal Endoscopy (ASGE) regarding the management of antithrombotic agents for endoscopy, aspirin and/or NSAIDs may be continued for all elective endoscopic procedures.
Meta-analysis of major clinical trials finds similar therapeutic benefits and risks of clopidogrel across wide spectrum of cardiovascular disease.
Proton pump inhibitors interfere with anti-clotting protection of clopidogrel.
The anti-clotting action of the medication clopidogrel -- Plavix -- can be compromised by common drugs for the treatment of heartburn, U.S. researchers said. Principal investigator Eric J.
By Jeanine Kendle Plavix (clopidogrel) is a fairly well-known drug with considerable media coverage for cardiac conditions to prevent platelet (blood cell component) aggregation (sticking/clumping together).
- Emitting flashes of light; glittering.